Fund Holdings — ADAR1 Capital Management, LLC

Total Portfolio Value:
$485.21M
Total Bought:
$146.38M
Total Sold:
$261.70M
Net Transaction:
-$115.32M
Notable People:
Daniel Pawel Schneeberger, Adar1 Capital Management Gp, Llc
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Roivant Sciences Ltd.SHS(ROIV)3,025,4503,508,694+483,244$34.91M$41.51M8.55%+$6.59M
Protagonist Therapeutics Inc981,2951,020,333+39,038$44.16M$39.38M8.12%-$4.77M
Ea Series TrustALPHA ARCH 1 3
ALPHA ARCH 1-3
323,382325,450+2,068$35.23M$35.89M7.40%+$664.6K
Zai Lab LimitedADR(ZLAB)532,4541,045,837+513,383$12.85M$27.39M5.65%+$14.54M
Immunovant, Inc.(IMVT)1,131,707787,478-344,229$32.26M$19.51M4.02%-$12.76M
Cytokinetics, Incorporated(CYTK)911,182414,209-496,973$48.11M$19.48M4.02%-$28.63M
BridgeBio Pharma, Inc.(BBIO)1,448,470678,857-769,613$36.88M$18.63M3.84%-$18.25M
Inhibikase Therapeutics, Inc.(IKT)05,103,005+5,103,005$0$16.58M3.42%+$16.58M
Spdr Ser TrBLOOMBERG 1 3 MO
ST STR BLO 1 ETF
21,786131,786+110,000$2.00M$12.05M2.48%+$10.05M
ABIVAX Société AnonymeADS(ABVX)521,6121,513,393+991,781$6.01M$11.08M2.28%+$5.07M
Mineralys Therapeutics, Inc.(MLYS)729,401841,541+112,140$8.83M$10.36M2.14%+$1.53M
Ascendis Pharma A/SADR(ASND)161,40271,402-90,000$24.10M$9.83M2.03%-$14.27M
Perceptive Cap Solutions CorCL A
CL A ORD SHS
750,000750,0000$7.51M$7.63M1.57%+$120.0K
Revolution Medicines, Inc.(RVMD)44,351170,000+125,649$2.01M$7.44M1.53%+$5.42M
Rezolute, Inc.(RZLT)1,571,7051,359,208-212,497$7.62M$6.66M1.37%-$962.6K
Endeavor Group Hldgs IncCL A122,807210,729+87,922$3.51M$6.59M1.36%+$3.09M
CG Oncology, Inc.(CGON)143,104215,750+72,646$5.40M$6.19M1.28%+$788.4K
Anteris Technologies Global Corp.(AVR)01,052,968+1,052,968$0$5.88M1.21%+$5.88M
Aa Mission Acquisition CorpCL A1,010,199560,199-450,000$10.12M$5.66M1.17%-$4.46M
Coherus Oncology, Inc.NOTE 1 500 4 1(CHRS)000$0$5.48M1.13%+$5.48M
Xencor, Inc.(XNCR)342,262234,607-107,655$6.88M$5.39M1.11%-$1.49M
Zura Bio LimitedCL A(ZURA)3,770,6492,077,251-1,693,398$15.31M$5.19M1.07%-$10.12M
Arbutus Biopharma Corporation(ABUS)2,089,3211,554,802-534,519$8.04M$5.08M1.05%-$2.96M
Oaktree Acquisition Corp IiiUNIT 10 04 2029
UNIT 10/04/2029
0500,000+500,000$0$5.07M1.04%+$5.07M
Sarepta Therapeutics, Inc.(SRPT)7,10040,002+32,902$886.7K$4.86M1.00%+$3.98M
SanofiADR(SNY)099,600+99,600$0$4.80M0.99%+$4.80M
Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS)000$0$4.36M0.90%+$4.36M
Helix Acquisition Corp IiCL A404,138404,1380$4.22M$4.24M0.87%+$20.2K
89bio Inc6,560515,138+508,578$48.5K$4.03M0.83%+$3.98M
BridgeBio Pharma, Inc.NOTE 2 250 2 0(BBIO)000$0$3.86M0.80%+$3.86M
Merus N V153,28681,460-71,826$7.66M$3.43M0.71%-$4.23M
Kiniksa Pharmaceuticals International, plcCL A(KNSA)436,668166,406-270,262$10.91M$3.29M0.68%-$7.62M
Aldeyra Therapeutics, Inc.(ALDX)302,212647,960+345,748$1.63M$3.23M0.67%+$1.60M
Teva Pharmaceutical Industries LimitedADS(TEVA)108,171146,671+38,500$1.95M$3.23M0.67%+$1.28M
Savara Inc.(SVRA)742,634988,468+245,834$3.15M$3.03M0.63%-$114.2K
Grace Therapeutics, Inc.(GRCE)959,571773,635-185,936$2.88M$2.89M0.60%+$14.7K
Monopar Therapeutics Inc.(MNPR)0130,037+130,037$0$2.86M0.59%+$2.86M
Crinetics Pharmaceuticals In88,42553,125-35,300$4.52M$2.72M0.56%-$1.80M
Tectonic Therapeutic, Inc.(TECX)127,15958,708-68,451$3.85M$2.71M0.56%-$1.14M
Rocket Pharmaceuticals, Inc.(RCKT)4,300211,400+207,100$79.4K$2.66M0.55%+$2.58M
Centessa Pharmaceuticals PlcADS23,302154,027+130,725$372.6K$2.58M0.53%+$2.21M
Aerovate Therapeutics Inc113,075928,016+814,941$236.3K$2.46M0.51%+$2.22M
Korro Bio, Inc.(KRRO)49,45157,978+8,527$1.65M$2.21M0.45%+$554.6K
PTC Therapeutics, Inc.(PTCT)20,00048,023+28,023$742.0K$2.17M0.45%+$1.43M
A Spac Iii Acquisition CorpUNIT 02 15 2029
UNIT 02/15/2029
0215,000+215,000$0$2.17M0.45%+$2.17M
BridgeBio Pharma, Inc.NOTE 2 500 3 1(BBIO)000$0$2.10M0.43%+$2.10M
Xenon Pharmaceuticals Inc.(XENE)27,90350,547+22,644$1.10M$1.98M0.41%+$882.9K
Apogee Therapeutics Inc57,18341,274-15,909$3.36M$1.87M0.39%-$1.49M
Rapt Therapeutics Inc7,5001,174,313+1,166,813$15.1K$1.86M0.38%+$1.84M
Delcath Systems, Inc.(DCTH)31,052149,385+118,333$280.4K$1.80M0.37%+$1.52M
Pliant Therapeutics, Inc.(PLRX)246,128134,798-111,330$2.76M$1.78M0.37%-$983.8K
Palvella Therapeutics, Inc.(PVLA)0144,641+144,641$0$1.74M0.36%+$1.74M
Rhythm Pharmaceuticals, Inc.(RYTM)030,941+30,941$0$1.73M0.36%+$1.73M
Janux Therapeutics, Inc.(JANX)13,00031,509+18,509$590.6K$1.69M0.35%+$1.10M
Axsome Therapeutics, Inc.(AXSM)60019,661+19,061$53.9K$1.66M0.34%+$1.61M
Soleno Therapeutics Inc10,00036,830+26,830$504.9K$1.66M0.34%+$1.15M
KALA BIO, Inc.(KALA)306,067220,373-85,694$1.74M$1.53M0.32%-$215.2K
Ares Acquisition Corp IiCL A138,966138,9660$1.51M$1.53M0.31%+$20.8K
Insmed Incorporated(INSM)3,63421,974+18,340$265.3K$1.52M0.31%+$1.25M
Avid Bioservices Inc0120,000+120,000$0$1.48M0.31%+$1.48M
Acelyrin Inc53,500444,967+391,467$263.8K$1.40M0.29%+$1.13M
Verona Pharma PlcADS10,00029,100+19,100$287.7K$1.35M0.28%+$1.06M
REGENXBIO Inc.(RGNX)569,008170,129-398,879$5.97M$1.32M0.27%-$4.65M
Poseida Therapeutics Inc0134,109+134,109$0$1.29M0.27%+$1.29M
Royalty Pharma plcCL A(RPRX)1,096,66649,963-1,046,703$31.02M$1.27M0.26%-$29.75M
Contineum Therapeutics, Inc.CL A(CTNM)8,96782,234+73,267$171.6K$1.20M0.25%+$1.03M
Alpha Cognition Inc. Common Stock(ACOG)0204,348+204,348$0$1.20M0.25%+$1.20M
Geron Corporation(GERN)557,159337,676-219,483$2.53M$1.20M0.25%-$1.33M
Lexeo Therapeutics, Inc.(LXEO)57,166169,505+112,339$516.8K$1.12M0.23%+$598.6K
Eli Lilly and Company(LLY)1,1501,350+200$1.02M$1.04M0.21%+$23.4K
iBio, Inc.CON NEW(IBIO)476,212415,606-60,606$1.06M$1.02M0.21%-$39.0K
Iteos Therapeutics Inc376,737131,599-245,138$3.85M$1.01M0.21%-$2.84M
Kezar Life Sciences Inc
COM NEW
1,338,273147,404-1,190,869$1.03M$990.6K0.20%-$44.2K
OmniAb, Inc.(OABI)1,337,302278,108-1,059,194$5.66M$984.5K0.20%-$4.67M
Regeneron Pharmaceuticals, Inc.(REGN)8711,361+490$915.6K$969.5K0.20%+$53.9K
Structure Therapeutics IncADS035,319+35,319$0$957.9K0.20%+$957.9K
Beam Therapeutics Inc.(BEAM)43,90038,312-5,588$1.08M$950.1K0.20%-$125.4K
MoonLake ImmunotherapeuticsCL A(MLTX)23,45717,424-6,033$1.18M$943.5K0.19%-$239.2K
Pfizer Inc.(PFE)35,95035,050-900$1.04M$929.9K0.19%-$110.5K
Fulcrum Therapeutics, Inc.(FULC)55,802196,248+140,446$199.2K$922.4K0.19%+$723.2K
Danaher Corporation(DHR)04,000+4,000$0$918.2K0.19%+$918.2K
Denali Therapeutics Inc.(DNLI)101,82644,826-57,000$2.97M$913.6K0.19%-$2.05M
Scholar Rock Holding Corporation(SRRK)12,00019,505+7,505$96.1K$843.0K0.17%+$746.9K
Agriculture & Nat Sol Acq CoCL A
SHS CL A
80,36280,3620$831.7K$843.0K0.17%+$11.3K
Spero Therapeutics, Inc.(SPRO)743,459801,277+57,818$996.2K$825.3K0.17%-$170.9K
Keen Vision Acquisition CorporationUNIT 99 99 9999(KVACF)75,00075,0000$804.8K$824.3K0.17%+$19.5K
Astria Therapeutics Inc93,28490,984-2,300$1.03M$813.4K0.17%-$213.7K
Capricor Therapeutics, Inc.(CAPR)24,30756,120+31,813$369.7K$774.5K0.16%+$404.7K
Neumora Therapeutics, Inc.(NMRA)068,608+68,608$0$727.2K0.15%+$727.2K
Voyager Therapeutics, Inc.(VYGR)40,634126,792+86,158$237.7K$718.9K0.15%+$481.2K
BioAge Labs, Inc.(BIOA)0123,037+123,037$0$712.4K0.15%+$712.4K
Alector Inc428,802368,330-60,472$2.00M$696.1K0.14%-$1.30M
Alnylam Pharmaceuticals, Inc.(ALNY)02,900+2,900$0$682.4K0.14%+$682.4K
Indivior Plc54,05754,0570$527.1K$671.9K0.14%+$144.9K
Day One Biopharmaceuticals I
COM
53,11153,023-88$739.8K$671.8K0.14%-$68.0K
Cidara Therapeutics Inc024,938+24,938$0$670.3K0.14%+$670.3K
Kiora Pharmaceuticals, Inc.(KPRX)196,551200,221+3,670$719.4K$660.7K0.14%-$58.6K
Protara Therapeutics, Inc.(TARA)0122,690+122,690$0$647.8K0.13%+$647.8K
Instil Bio, Inc.(TIL)23,70731,708+8,001$1.60M$605.3K0.12%-$990.6K
Organon & Co.(OGN)3,10040,200+37,100$59.3K$599.8K0.12%+$540.5K
Page 1 of 4
ADAR1 Capital Management, LLC — 13F Holdings — Q4 2024 | TickerTrail